自愿高通风诱导的低头症可以提高Wingate测试的性能,而不会改变能源系统的贡献
Hasan Hüseyin Yılmaz1,2, Süleyman Ulupınar3, Fatih Kıyıcı4,5
1Faculty of Sports Sciences, Atatürk University, Erzurum, Turkey. hasanh.yilmaz@atauni.edu.tr.
BMC sports science, medicine & rehabilitation
|July 3, 2025
概括
在运动员中,自愿高通风通过诱导低头症显著提高了运动员在高强度运动期间的峰值和平均功率. 这一策略可以提高无氧性能,而不会改变潜在的能源系统贡献.
科学领域:
- 运动生理学 运动生理学
- 运动科学 运动科学 运动科学
- 人类表现的人类表现.
背景情况:
- 高强度的运动挑战了酸平衡,离子 (H+) 积累限制了性能.
- 自愿高通风可以诱导低头 (减少血液中的二氧化碳),可能会影响运动反应.
- 对于运动员来说,了解运动前低头症对无氧性能和能量代谢的影响至关重要.
研究的目的:
- 为了研究自愿高通风诱导的低头症对团队体育运动运动员的Wingate测试表现的影响.
- 评估在高强度运动期间低头对能量系统贡献 (氧化,糖解,ATP-PCr) 的影响.
- 为了确定高通风是否会改变运动后血液中乳糖的积累.
主要方法:
- 17名男子团队运动运动员在控制和高通风条件下进行了30秒的Wingate测试.
- 高通风需要5分钟的受控呼吸 (1000毫升的潮体积,30次呼吸·分钟-1),以诱导低头症.
- 性能 (峰值/平均功率),能量系统贡献和血液乳酸被测量使用气体分析和血液采样.
主要成果:
- 与对照条件相比,高通风显著增加了相对峰值功率 (p=0.007) 和平均功率 (p=0.005).
- 在氧化,糖溶性或ATP-PCr能量系统的贡献中没有发现显著差异.
- 总能耗和血液中的乳酸盐积累 (Δ[BLa−]) 在不同的条件之间保持不变.
结论:
- 运动前的高通风可以提高运动员在短时间,高强度无氧性能的表现,而不会改变能量代谢.
- 潜在的机制包括改善缓冲能力,增强神经肌肉激活或改变氧气再分配.
- 这种内生策略提供了一种优化性能的实用方法,需要在不同的协议和群体中进行进一步的研究.
更多相关视频
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
875
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
6.1K
相关概念视频
Hyperpnea and Hyperventilation
1.3K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.3K
Alterations in Respiration II
1.0K
There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.0K
Chemical Factors Affecting Respiration Centers
1.3K
Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated....
CO2 has a potent influence on respiration and is strictly regulated....
1.3K
Physiological Control of Respiration
3.6K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
3.6K
Acute Respiratory Failure-III
335
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
335
Acute Respiratory Failure-II
377
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
377
